Facility
CAREFUSION
4 recall(s) on record — most severe on record: Class II.
| FDA Establishment Identifier (FEI) | 3012410077 |
|---|---|
| Establishment type | Develop Specifications But Do Not Manufacture At This Facility |
| Location | 3750 Torrey View Court San Diego, CA, US 92130 |
| Registration status | Active · expires 2026 |
| Parent company | CareFusion (owner-operator 10069801) |
| Brand names | set, administration, intravascular |
Devices registered here (1)
- Set, Administration, IntravascularProduct code FPA · Class II · General Hospital · 21 CFR 880.5440
Recalls & enforcement
- Class IIOngoing2022-08-01Administration set, and extension set product labels list expiration year 2027 but the labels should list expiration year 2025. If expired product is used, the integrity of the product may be compromised, and may result in potential leaks and risk of infection to the patient and
- Class IIOngoing2021-08-02Needle-free connector valves, either standalone or attached to extension sets, may have issues including difficulty to flush, flow issues, and partial or total occlusions, which could lead to therapy delay. Follow-up activates not required if product has already been used or was
- Class IITerminated2021-06-09A portion of a validation lot was inadvertently released to the US Market. The product did not meet the validation testing criteria regarding leakage.
- Class IITerminated2009-11-20The recall was initiated because Carefusion has confirmed that when the PAS 2000 drawers due to inaccessability of drawers caused by system down time or lock-up.
Related
Source: U.S. FDA via openFDA (device registration & enforcement). Data as of 2026-08-13. Verify this facility record at FDA →
Watch CAREFUSION
We'll email you when a new FDA recall or enforcement record is published for a facility you follow. (Inspection & warning-letter coverage is being added.)
Want a one-page facility brief?
A single-page summary of this facility's registration and recall history for diligence. Not selling it yet — register interest and we'll follow up.